Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
Mezynski, J., Pezaro, C., Bianchini, D., Zivi, A., Sandhu, S., Thompson, E., Hunt, J., Sheridan, E., Baikady, B., Sarvadikar, A., Maier, G., Reid, A.H.M., Mulick Cassidy, A., Olmos, D., Attard, G., de Bono, J.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
31 Evaluating the antitumour activity of docetaxel following treatment with abiraterone acetate and steroids: Evidence for cross-resistance
Mezynski, J, Attard, G, Zivi, A, Bianchini, D, Sandhu, S, Cassidy, A. Mulick, Thompson, E, Reid, A, Baikady, B, de Bono, J.S
Published in Critical reviews in oncology/hematology (2011)
Published in Critical reviews in oncology/hematology (2011)
Get full text
Journal Article
1717P Management of patients during a digital healthcare record system transition: A phase I unit experience
Del Rosario, L., Rao Baikady, B., Rodney, S., Gurung, S., Hammond, S., Cortes, F., MohamedKhan, S., Livings, C., Clark, T., Daly, R., Silva Fortes, G., Horvath, K., Lamb, P., Little, A., de Bono, J.S., Banerji, U., Minchom, A.R., Lopez, J.S., Sharp, A., Paschalis, A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?
Mezynski, J, Pezaro, C, Bianchini, D, Zivi, A, Sandhu, S, Thompson, E, Hunt, J, Sheridan, E, Baikady, B, Sarvadikar, A, Maier, G, Reid, A H M, Mulick Cassidy, A, Olmos, D, Attard, G, de Bono, J
Published in Annals of oncology (01.11.2012)
Get full text
Published in Annals of oncology (01.11.2012)
Journal Article